Spondylosis
37
5
5
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.8%
4 terminated out of 37 trials
81.8%
-4.7% vs benchmark
3%
1 trials in Phase 3/4
44%
8 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (37)
Perioperative ACT for Preventing CPSP
Proprio Spine Measurement Tool
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery
Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®
CEM-Plate and CEM-Cage First-In-Human Use Efficacy Study
Recording of Intraoperative Spinal Cord Stimulation and Monitoring
ViBone in Cervical and Lumbar Spine Fusion
PREventing Pain After Surgery
Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
Return of Bowel Function After One or Two Level Anterior Lumbar Interbody Fusion With Chewing Gum
Single-Armed Use of ViviGen Cellular Bone Matrix in Patients Undergoing Posterolateral Lumbar Surgery
RHINE™ Cervical Disc Clinical Study: A Prospective Observational Study for Patients Requiring 1-2 Level C-spine Surgery
Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes
UNiD 3D VBR Register
Mulligan Mobilizations and McKenzie Exercises Along With Neural Mobilizations in Cervical Spondylosis
Physical Activity Intervention for Patients Following Lumbar Spine Surgery
Neurology Inpatient Clinical Education Trial
Study of Nucel for One and Two Level Lumbar Interbody Fusion
Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion